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Sudden unexpected death in epilepsy
A B S T R A C T
Since almost 20 y it is known that seizures may trigger Takotsubo syndrome (TTS). Since then it has been
repeatedly proposed that TTS could be the cause of sudden unexpected death in epilepsy (SUDEP).
A review of the so far reported cases of seizure-triggered TTS was carried out to see how often seizure-
triggered TTS is fatal.
Altogether 59 papers were identiﬁed which reported altogether 74 patients with seizure-triggered
TTS. Age was reported in 70 patients and ranged from 18 to 82 y. Gender was reported in 70 cases and
was female in 60 cases (86%). The type of triggering seizure was reported in 47 cases. In 28 patients (60%)
the trigger was a generalized tonic clonic seizure, in 15 cases (32%) a generalized status epilepticus, and
in 3 cases a complex partial seizure. The outcome was mentioned in 63 of the 74 patients. Full recovery
was reported in 61 cases (97%), incomplete recovery in none of the patients, and a fatal outcome in 2
patients (3%).
Fatalities are rare in patients experiencing seizure-triggered TTS. This is why seizure-triggered TTS
does not seem to play a major role in the pathogenesis of SUDEP.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Central nervous system (CNS) disease is increasingly recognized
as a trigger of Takotsubo syndrome (TTS), also known as Tako-tsubo
cardiomyopathy, ampulla cardiomyopathy, apical ballooning,
neurogenic stress cardiomyopathy, broken heart syndrome, neuro-
genic stunned myocardium, transient regional left ventricular
dysfunction, transient myocardial dysfunction, transient systolic
dysfunction, neurogenic stressed myocardium, catecholamine
cardiomyopathy, or reversible acute heart failure [1,2]. TTS mimics
myocardial infarction clinically, electrocardiographically, and
chemically. Clinically, TTS is characterized by acute onset chest
pain and dyspnea, occasionally associated with palpitations,
coughing, edema, tiredness, syncope, fever, nausea, vomiting, or
anxiety [3]. Creatine-kinase (CK), troponin-T, and proBNP may be
elevated. Electrocardiography (ECG) may show initial ST-elevation,
which dynamically changes to negative T-waves, and ﬁnally
complete resolution of the abnormalities [4]. Echocardiography
may show segmental hypokinesia or akinesia and reduced systolic
function and compensatory hyperkinesia of segments not affected
by the stunning. Most frequently, stunning affects the apical or* Corresponding author. Tel.: +43 1 71165 92085; fax: +43 1 4781711.
E-mail address: ﬁﬁgs1@yahoo.de (J. Finsterer).
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights remidventricular segments of the left ventricular myocardium
(classical type), but rarely also the midventricular segments
(midventricular type), the basal or midventricular segments
(inverted type), or all segments (global type) are affected [2].
According to a recent review [3], the CNS disorder most frequently
triggering TTS is subarachnoid bleeding but the CNS disorder second
most frequently triggering TTS is epilepsy [3]. This mini-review
aimed at highlighting recent advances concerning the prevalence,
age at occurrence, gender distribution, TTS type, and outcome of TTS
triggered by epileptic seizures or an epileptic state. Additionally, we
were interested in the cause of epilepsy, the seizure type, and the
antiepileptic drug (AED) therapy prior to the TTS.
2. Methods
Data for this review were retrieved by searches of MedLine and
references from relevant articles using the search terms ‘‘epilepsy’’
and ‘‘seizures’’ combined with ‘‘Takotsubo syndrome’’, ‘‘Takotsubo
cardiomyopathy’’, ‘‘ampulla cardiomyopathy’’, ‘‘stress cardiomy-
opathy’’, ‘‘apical ballooning’’, ‘‘broken heart syndrome’’, and
‘‘stunned myocardium’’. Randomized (blinded or open label)
clinical trials, longitudinal studies, case series, and case reports
were pondered. Only articles published in English between 1966
and 2015 were considered. Appropriate papers were studied and
discussed for their suitability to be incorporated in this review.served.
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Altogether 59 papers matching the search terms were selected.
Full access was available to 47 articles (80%) and 12 papers were
accessible only as an abstract. Fifty-one papers were case reports or
single cases with epilepsy in a cohort study. Eight papers reported
more than 1 patient but none of the papers reported more thanTable 1
Seizures triggering TTS.
Cause of epilepsy ST AED at TTS NOP Sex 
Nm nm nm 5 f 
Nm nm nm 3 nm 
Nm TCS nm 3 f 
Nm SE nm 3 2f, 1 m
Stroke, alcohol, amitryptillin nm nm 3 2f, 1 m
Nm nm nm 2 f 
Nm/psychosis TCS PHT/LEV, CBZ 2 f 
SAB/ICB TCS nm 2 1 m, 1f
Nm nm nm 1 nm 
Nm nm nm 1 f 
Previous stroke nm VPA 1 f 
Bleeding right frontotemporal sTCS PHT, LEV 1 f 
Genetic CPS ZNS, LMT 1 f 
Previous stroke TCS PHT 1 f 
Genetic SE None 1 f 
Alcohol withdrawal nm LEV 1 f 
Genetic TCS CBZ, VPA, PRM 1 f 
Nm TCS None 1 f 
Cryptogenic, left temporal SE VPA, ZNS, DZP 1 f 
Nm TCS, SE CBZ 1 f 
Subarachnoid bleeding TCS None 1 f 
Nm SE LEV, CLB 1 f 
Na SE na 1 f 
Trauma SE nm 1 m 
Alcohol TCS None 1 m 
Genetic TCS None 1 f 
Stroke nm nm 1 m 
Anesthesia NES na 1 f 
Previous stroke TCS None 1 f 
Genetic TCS VPA 1 f 
Na na na 1 f 
Subdural hematoma CPS CBZ 1 m 
Nm TCS None 1 f 
Cavernoma bleeding TCS None 1 f 
Right mesial temporal sclerosis sTCS CBZ, PHT, ZNS,
TPM
1 f 
Alcohol nm None 1 f 
Nm nm nm 1 f 
Cavernoma mesotemporal TCS GBT 1 f 
Na Na na 1 f 
Stroke CPS nm 1 f 
Nm nm nm 1 f 
Opiate withdrawal TCS None 1 f 
PRES SE None 1 f 
Nm nm nm 1 m 
Electroconvulsive therapy TCS None 1 f 
Nm nm nm 1 f 
Ischemic stroke TCS nm 1 f 
Ischemic stroke TCS, SE nm 1 f 
Genetic TCS, SE nm 1 m 
Genetic TCS, SE DZP, PHT, VPA 1 f 
PRES TCS None 1 f 
Mesiotemporal sclerosis TCS, SE CBZ, LEV 1 f 
Genetic TCS CBZ, PHT 1 f 
Multiple sclerosis TCS None 1 f 
Astrocytoma surgery TCS, SE na 1 f 
Alcohol withdrawal na na 1 f 
Genetic TCS None 1 f 
Left frontal hypodensitiy nm nm 1 m 
Nm TCS nm 1 f 
AED, antiepileptic drug; ST, seizure type; NOP, number of patients; TTST, TTS-type; TTST
subarachnoid bleeding; ICB, intracerebral bleeding; PRES, posterior reversible encepha
seizure; SE, status epilepticus; NES, non-epileptic seizure; f, female; m, male; FR, full 
accessible; CLB, clobazam; DZP, diazepam; PHT, phenytoin; CBZ, carbamazepine; VPA, val
TPM, topiramate; BB, beta-blockers; ACEI, angiotensin converting enzyme inhibitors; H5 patients (Table 1). Altogether, 74 patients with epilepsy-
triggered TTS were identiﬁed (Table 1). Among the nine papers
reporting >2 patients, all were accessible as full papers. In the
study with 5 patients nothing is reported about the cause, type, or
treatment of seizures [5]. None of the ﬁve patients experienced
cardiac symptoms prior or during hospitalization [5]. The only
indication for cardiac disease in these 5 patients was elevatedAge TTST TTSTr OC Reference FP/AB
49–78 nm nm FR [5] FP
nm nm nm nm [9] FP
43–80 Classic nm FR [10] FP
 18–47 Global nm nm [11] FP
 40–73 nm nm FR [6] FP
41 + 78 Classic nm FR [12] FP
63/50 Classic BB, ACEI FR [13] FP
 50 + 62 Mid HFT FR [14] FP
nm nm nm nm [15] AB
73 Classic None FR [16] FP
68 Classic nm na [17] AB
55 Classic Stent FR [18] FP
19 nm None nm [7] FP
44 Classic ACEI FR [19] FP
47 Classic nm FR [20] FP
57 Classic HFT FR [21] FP
67 Classic None FR [22] FP
50 Classic BB, ACEI FR [23] FP
43 Classic None FR [24] FP
68 Classic None FR [25] FP
60 Classic None FR [26] FP
79 Classic None FR [27] FP
50 Classic nm FR [28] AB
50 Classic None FR [29] FP
63 Classic None FR [30] FP
69 Classic nm FR [31] AB
78 Classic nm Death [32] FP
67 Mid nm FR [33] AB
67 Classic None FR [34] FP
81 Classic nm FR [35] FP
59 nm nm nm [36] AB
73 nm nm nm [37] AB
50 Classic nm FR [38] AB
74 Classic None FR [39] FP
51 Classic None FR [40] FP
25 Classic nm FR [41] AB
75 MId nm nm [42] FP
71 Classic None Death [43] FP
42 Mid nm FR [44] AB
75 Classic nm FR [45] FP
79 Classic nm FR [46] FP
58 Classic BB FR [47] FP
82 Classic None FR [48] FP
57 Classic Dobutamine FR [49] FP
71 Classic None FR [50] FP
77 Mid nm FR [51] FP
62 Classic ACEI, DR FR [52] FP
54 Classic ACEI, DR FR [53] FP
62 Mid None FR [54] FP
75 Classic Nitro FR [55] FP
55 Classic None FR [56] FP
61 Classic BB, DR FR [57] FP
64 Classic BB, DR FR [58] FP
69 Classic None FR [59] FP
59 Classic nm FR [60] AB
49 Classic nm FR [61] AB
82 Classic None FR [62] FP
39 Inverted nm FR [63] FP
67 Classic nm FR [64] FP
r, treatment of TTS; OC, outcome; FP/AB, full paper or only abstract available; SAB,
lopathy syndrome; CPS, complex partial seizures; (s)TCS, (secondary) tonic clonic
recovery; IR, incomplete recovery; *, epileptic state; nm, not mentrioned; na, not
proic acid; LEV, levetirazetam; LMT, lamotrigine; ZNS, zonisamide; PRM, primidone;
FT, heart failure therapy; DR, diuretics.
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revealing TTS. The ﬁrst paper about seizure-triggered TTS was
provided by Sharkey et al. in 1998. In a series of 22 patients with
TTS, three had generalized seizures prior to the development of TTS
[6]. Two of them were female, age ranged between 40 and 73 y, and
all had a favorable outcome. Unfortunately, no information about
the cause and treatment of epilepsy and the TTS type were
provided [6]. Among all 74 patients with seizure-triggered TTS so
far reported, age was reported in 70 patients, ranging from 18 to
82 y. Gender was reported in 70 cases and was female in 60 (86%)
and male in 10 (14%) cases. The type of triggering seizure was
reported in 47 cases. In 28 patients (60%) the trigger was a
generalized tonic clonic seizure (TCS), in 15 cases (32%) a
generalized status epilepticus, and in 3 cases a complex partial
seizure (Table 1). Data about the antiepileptic medication prior to
TTS were provided for 18 patients. In some studies it was unclear if
the given AED was taken already prior to TTS or prescribed after the
triggering seizure. The type of TTS was reported in 59 patients, of
which 48 (81%) presented with the classical type, 7 with the
midventricular type, 1 with the inverted (inverse) type, and 3 with
the global type (Table 1). Treatment for TTS was given in 15 cases
(Table 1). No treatment for TTS was provided in 19 cases. Only 1 of
those who received no treatment died. The outcome was reported
in 63 of the 74 patients so far published. Full recovery of TTS was
reported in 61 cases (97%), incomplete recovery in none of the
patients, and a fatal outcome in 2 patients (3%).
4. Discussion
This mini-review shows that TTS is increasingly recognized as a
possible complication of generalized seizures. Diagnosing TTS in
patients after a seizure is essential since treatment of TTS may
improve the outcome of affected patients. However, of the 19
patients who did not receive treatment only one died and of the 14
patients who received treatment, none died. Though it is
speculated that TTS is one possible mechanism to explain sudden
unexpected death in epilepsy (SUDEP), the present review argues
against a strong causal relation. Only 3% of the patients with
seizure-triggered TTS died during or after the event. In 97% of the
cases the outcome of seizure-triggered TTS was favorable,
irrespective if TTS was treated or not, suggesting that TTS without
complications is not responsible for SUDEP in a signiﬁcant number
of cases. Only if TTS is complicated by non-sustained ventricular
arrhythmias or asystole it is conceivable that TTS secondarily
causes SUDEP. More frequently than uncomplicated TTS, ventric-
ular arrhythmias or a pulmonary complication may cause SUDEP. A
further argument against a strong role of TTS in the pathomechan-
ism of SUDEP is that TTS generally carries a favorable outcome,
disregarding the underlying trigger. Only in patients with
subarachnoid bleeding the outcome of TTS is fatal in 34%, and
thus higher compared to patients with seizure-triggered TTS,
possibly due to the increased mortality of the underlying
neurologic disease.
In conclusion this minireview shows that seizure-triggered
TTS has been reported in 74 cases since its ﬁrst description in
1998 [6]. No information about the prevalence of TTS among
epilepsy patients has been provided so far. Age at occurrence of
TTS ranges from 18 to 82 y [7,8]. There is a striking female
preponderance. All types of TTS may be triggered by seizures but
the classical type prevails. The outcome is favorable in 97% of the
cases, irrespective of treating or not treating TTS, making it rather
unlikely that TTS plays a strong role in the pathomechanism of
SUDEP. It appears that patients with generalized seizures do not
need to receive beta-blockers for prophylactic reasons to prevent
TTS.Financial disclosure statement
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